Back to News
Market Impact: 0.25

UNH Quantitative Stock Analysis

UNHNDAQ
Company FundamentalsCorporate EarningsAnalyst InsightsInsider TransactionsHealthcare & Biotech
UNH Quantitative Stock Analysis

Validea's guru fundamental report rates UNITEDHEALTH GROUP INC (UNH) at 77% using its Martin Zweig Growth Investor model, a strategy known for its historical outperformance. While UNH, a large-cap health insurer, passes key criteria like P/E ratio and current quarter earnings, its overall score falls just shy of the 80% threshold for strategic interest, primarily due to inconsistencies in revenue growth relative to EPS and earnings growth over the past several quarters.

Analysis

UnitedHealth Group (UNH) receives a 77% rating from Validea's Martin Zweig-based Growth Investor model, indicating a fundamentally sound company that falls just short of the 80% threshold for a clear buy signal under this specific quantitative strategy. The analysis reveals a bifurcated performance profile. On the positive side, UNH passes crucial tests for its P/E ratio, sales growth rate, long-term EPS growth, earnings persistence, and favorable insider transactions. The current quarter's earnings performance is particularly strong, showing positive growth and exceeding the growth rates of the prior three quarters. However, the model flags significant inconsistencies in growth acceleration, which are central to the Zweig methodology. UNH fails the criteria for revenue growth relative to EPS growth, earnings growth rate over the past several quarters, and its current EPS growth fails to exceed its historical rate. This suggests that while current performance is robust, the longer-term trend lacks the persistent acceleration that the model seeks for a high-conviction investment.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo

Market Sentiment

Overall Sentiment

mildly positive

Sentiment Score

0.35

Ticker Sentiment

NDAQ0.00
UNH0.50

Key Decisions for Investors

  • Given the failure to meet key growth acceleration metrics, investors following a strict momentum or growth-acceleration strategy should exercise caution, as the stock does not currently exhibit the consistent, accelerating profile required by the Zweig model.
  • For investors with a 'Growth at a Reasonable Price' (GARP) perspective, the combination of a passing P/E ratio, strong current-quarter earnings, and positive insider activity may present an opportunity, provided they are comfortable with the noted lack of earnings momentum.
  • Monitor upcoming quarterly reports closely for two key indicators: a re-acceleration in the multi-quarter earnings growth trend and an improved alignment between revenue and EPS growth, as improvements here would be necessary to clear the model's primary hurdles.